BG62475B1 - Приложение на2-амино-6-n-пропиламино-4,5,6,7-тетрахидробензотиазол за лечениена депресия - Google Patents

Приложение на2-амино-6-n-пропиламино-4,5,6,7-тетрахидробензотиазол за лечениена депресия Download PDF

Info

Publication number
BG62475B1
BG62475B1 BG99700A BG9970095A BG62475B1 BG 62475 B1 BG62475 B1 BG 62475B1 BG 99700 A BG99700 A BG 99700A BG 9970095 A BG9970095 A BG 9970095A BG 62475 B1 BG62475 B1 BG 62475B1
Authority
BG
Bulgaria
Prior art keywords
propylamino
amino
tetrahydrobenzothiazole
application
treatment
Prior art date
Application number
BG99700A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99700A (bg
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of BG99700A publication Critical patent/BG99700A/bg
Publication of BG62475B1 publication Critical patent/BG62475B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BG99700A 1992-12-05 1995-06-05 Приложение на2-амино-6-n-пропиламино-4,5,6,7-тетрахидробензотиазол за лечениена депресия BG62475B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (2)

Publication Number Publication Date
BG99700A BG99700A (bg) 1996-04-30
BG62475B1 true BG62475B1 (bg) 1999-12-30

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99700A BG62475B1 (bg) 1992-12-05 1995-06-05 Приложение на2-амино-6-n-пропиламино-4,5,6,7-тетрахидробензотиазол за лечениена депресия

Country Status (29)

Country Link
US (1) US6191153B1 (ru)
EP (1) EP0675717B1 (ru)
JP (1) JP3221880B2 (ru)
KR (1) KR100311165B1 (ru)
CN (1) CN1052400C (ru)
AT (1) ATE183091T1 (ru)
AU (1) AU674378B2 (ru)
BG (1) BG62475B1 (ru)
CA (1) CA2150131C (ru)
CZ (1) CZ282679B6 (ru)
DE (2) DE4241013A1 (ru)
DK (1) DK0675717T3 (ru)
ES (1) ES2136725T3 (ru)
FI (1) FI952734A (ru)
GR (1) GR3031521T3 (ru)
HK (1) HK1019003A1 (ru)
HU (1) HU221014B1 (ru)
IL (1) IL107870A (ru)
MX (1) MX9307644A (ru)
NO (1) NO306930B1 (ru)
NZ (1) NZ258876A (ru)
PL (1) PL309282A1 (ru)
RU (1) RU2157685C2 (ru)
SG (1) SG49228A1 (ru)
SK (1) SK281441B6 (ru)
TW (1) TW362973B (ru)
UA (1) UA35604C2 (ru)
WO (1) WO1994013287A1 (ru)
ZA (1) ZA939065B (ru)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
AU7887501A (en) * 2000-07-06 2002-01-21 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
PE20040134A1 (es) * 2002-07-25 2004-03-06 Pharmacia Corp Forma de dosificacion de una vez al dia de pramipexol
DE102004006808A1 (de) * 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
EP1778201B1 (en) * 2004-08-13 2014-07-16 Boehringer Ingelheim International GmbH Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
PL1789021T3 (pl) * 2004-08-13 2012-04-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
UA89397C2 (ru) * 2005-04-04 2010-01-25 Такеда Фармасьютикал Компани Лимитед Средство для профилактики или лечения депрессивных или тревожных расстройств
EP1940398A1 (de) * 2005-10-18 2008-07-09 Boehringer Ingelheim International GmbH Verwendung von pramipexol zur behandlung des moderaten bis schweren restless legs syndroms (rls)
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
US20090041844A1 (en) * 2006-02-10 2009-02-12 Boehringer Ingelheim International Gmbh Modified Release Formulation
EP3609495B1 (en) * 2017-04-10 2024-07-24 Chase Therapeutics Corporation Nk1-antagonist combination and method for treating synucleinopathies
IL271464B2 (en) 2017-06-30 2024-08-01 Chase Therapeutics Corp NK-1 antagonist compositions and methods for use in the treatment of depression
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
DE4241013A1 (de) 1994-06-09
SG49228A1 (en) 1998-05-18
FI952734A0 (fi) 1995-06-05
AU5715294A (en) 1994-07-04
BG99700A (bg) 1996-04-30
NO952207D0 (no) 1995-06-02
MX9307644A (es) 1994-06-30
DE59309733D1 (de) 1999-09-16
EP0675717A1 (de) 1995-10-11
AU674378B2 (en) 1996-12-19
NZ258876A (en) 1997-07-27
NO306930B1 (no) 2000-01-17
FI952734A (fi) 1995-06-05
IL107870A (en) 1996-12-05
CA2150131A1 (en) 1994-06-23
CN1091635A (zh) 1994-09-07
SK74095A3 (en) 1996-05-08
JP3221880B2 (ja) 2001-10-22
TW362973B (en) 1999-07-01
US6191153B1 (en) 2001-02-20
GR3031521T3 (en) 2000-01-31
RU2157685C2 (ru) 2000-10-20
HUT71798A (en) 1996-02-28
NO952207L (no) 1995-06-02
HK1019003A1 (en) 2000-01-14
ES2136725T3 (es) 1999-12-01
PL309282A1 (en) 1995-10-02
CZ144095A3 (en) 1996-03-13
UA35604C2 (ru) 2001-04-16
ATE183091T1 (de) 1999-08-15
IL107870A0 (en) 1994-04-12
ZA939065B (en) 1994-08-04
KR950703953A (ko) 1995-11-17
HU221014B1 (hu) 2002-07-29
SK281441B6 (sk) 2001-03-12
DK0675717T3 (da) 2000-02-28
WO1994013287A1 (de) 1994-06-23
CN1052400C (zh) 2000-05-17
HU9501623D0 (en) 1995-08-28
JPH08504201A (ja) 1996-05-07
CA2150131C (en) 2004-09-21
KR100311165B1 (ko) 2001-12-28

Similar Documents

Publication Publication Date Title
BG62475B1 (bg) Приложение на2-амино-6-n-пропиламино-4,5,6,7-тетрахидробензотиазол за лечениена депресия
US4070494A (en) Enteral pharmaceutical compositions
EP0317878B1 (de) Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen
US3636219A (en) Anticholinergic compositions containing certain thiazolines or imidazolines
FI101040B (fi) Menetelmä sentraalisten dopamiininpuutostilojen hoitoon tarkoitetun, p eroraalisesti annettavan lääkemuodon valmistamiseksi
CZ147494A3 (en) Pharmaceutical preparation and process for preparing thereof
CA2036375A1 (en) Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis
EP1655029B1 (en) Medicinal compositions
NL192870C (nl) Anti-hypertensief oraal farmaceutisch preparaat.
EP0205865A1 (de) Pharmazeutische Präparate mit antihypertensiver und kardioprotektiver Wirkung
IE66378B1 (en) Solid oral forms of application containing ifosfamide as active substance
HU203282B (en) Process for producing pharmaceutical composition for treating cardiac decomposition containing 7,8-dimethoxy-3-/3-(/2-(3,4-dimethoxy-phenyl)-ethyl/-methyl- -amino)-propyl/-1,3,4,5-tetrahydro-2h-3-benzazepin-2-one
CN114917213B (zh) 包含阿米替林的精神疾病治疗剂和治疗精神疾病的方法
CN101919851B (zh) 治疗哺乳动物包括人2型糖尿病的药物组合物
GB2141027A (en) Diltiazem hypolipidemic compositions
EP0273253A2 (de) Verwendung von 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[5,4-d]azepin zur Freisetzung von Wachstumshormon
US3495005A (en) Compositions and methods for suppressing appetite with combinations of amphetamine and thioridazine
DE3686538T2 (de) Verwendung von dibenz(cd,f)indol-derivaten zur praevention vom alkoholmissbrauch.
KR100701409B1 (ko) 호박산 수마트립탄을 함유하는 약제학적 조성물
JPS6110510A (ja) 免疫抑制作用を有する新規な医薬組成物
KR950005869B1 (ko) 위염 치료제
US5238946A (en) Therapeutic agent for gastritis
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
JPH03255026A (ja) 物質依存症に関する治療薬
WO2003061654A1 (de) Pramipexol zur behandlung von hiv demenz